glp-1 and potassium DPP4 Inhibitors vs Agonists | June 2021 | Clinical Corner Your body already makes the

Schedule Once daily

The efficacy of lowering glycated haemoglobin with a gliclazide modified release-based intensive glucose lowering regimen in the ADVANCE trial

Rubino DM, Greenway FL, Khalid U, ONeil PM, Rosenstock J, Srrig R, Wadden TA, Wizert A, Garvey WT, STEP 8 Investigators, Arauz-Pacheco C, Cannon K, Downey HJ, Fitz-Patrick D, Geohas J, Gerety G, Gilbert J, Hollander P, Klein E, Laufer K, ODonnell P, Rosenblit P, Toth P

doi:10.1016/j.pharmthera.2006.03.003 165

As we age, the efficiency of various cellular processes declines

This was not a focus of our previous research, but it is something we are now looking more into